FBXO11 and acute myeloid leukemia: AML samples had significantly reduced MMP compared with CD34+ HSPC (Figure 6M), and there was a significant correlation between FBXO11 protein abundance and MMP (Figure 6N), as well as significant negative correlation between leukemic cell burden and MMP in these samples (Figure 6O).